BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2657920)

  • 1. Clinic manifestations in granulomatosis with polyangiitis.
    Greco A; Marinelli C; Fusconi M; Macri GF; Gallo A; De Virgilio A; Zambetti G; de Vincentiis M
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):151-9. PubMed ID: 26684637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement].
    Laudien M; Ambrosch P; Till A; Podschun R; Lamprecht P
    Z Rheumatol; 2008 Sep; 67(5):397-406. PubMed ID: 18600330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect immunofluorescence study of the cornea and the conjunctiva in a xenogeneic system: analysis of humoral reactivity in patients with Wegener's granulomatosis.
    Przyklang U; Nölle B; Reinhold-Keller E; Duncker G
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):79-86. PubMed ID: 8720676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing vasculitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions.
    Gindre D; Peyrol S; Raccurt M; Sommer P; Loire R; Grimaud JA; Cordier JF
    Virchows Arch; 1995; 427(4):385-93. PubMed ID: 8548123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
    Gross WL; Schmitt WH; Csernok E
    Clin Exp Immunol; 1993 Jan; 91(1):1-12. PubMed ID: 8419069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in Wegener's granulomatosis.
    Briedigkeit L; Kettritz R; Göbel U; Natusch R
    Postgrad Med J; 1993 Nov; 69(817):856-61. PubMed ID: 8290430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin.
    Richter C; Schnabel A; Csernok E; De Groot K; Reinhold-Keller E; Gross WL
    Clin Exp Immunol; 1995 Jul; 101(1):2-7. PubMed ID: 7621588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.
    Steppat D; Gross WL
    Klin Wochenschr; 1989 Jul; 67(13):666-71. PubMed ID: 2787871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis.
    Csernok E; Lüdemann J; Gross WL; Bainton DF
    Am J Pathol; 1990 Nov; 137(5):1113-20. PubMed ID: 2240162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory diseases.
    James DG; Sharma OM
    Postgrad Med J; 1990 Jan; 66(771):1-15. PubMed ID: 2190199
    [No Abstract]   [Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.
    Gross WL; Csernok E; Schmitt WH
    Klin Wochenschr; 1991 Sep; 69(13):558-66. PubMed ID: 1721666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.
    Lüdemann J; Utecht B; Gross WL
    J Exp Med; 1990 Jan; 171(1):357-62. PubMed ID: 1688612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues.
    Braun MG; Csernok E; Gross WL; Müller-Hermelink HK
    Am J Pathol; 1991 Oct; 139(4):831-8. PubMed ID: 1656761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wegener's granulomatosis. New aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment.
    Gross WL
    Sarcoidosis; 1989 Mar; 6(1):15-29. PubMed ID: 2657920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wegener's granulomatosis: immunologic aspects of diagnosis, etiology and therapy].
    Gross WL
    Immun Infekt; 1987 Feb; 15(1):15-25. PubMed ID: 3552963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences with Wegener's granulomatosis from the nephrologic viewpoint].
    Zach R; Roob JM; Horn S; Kaufmann P; Winkler HM; Holzer H; Tilz GP; Pogglitsch H
    Wien Klin Wochenschr; 1991; 103(17):528-32. PubMed ID: 1949812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous vasculitis. Wegener's granulomatosis and Churg-Strauss syndrome.
    Specks U; DeRemee RA
    Rheum Dis Clin North Am; 1990 May; 16(2):377-97. PubMed ID: 2189156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticytoplasmic antibodies as serological markers and activity parameters of Wegener's granulomatosis. A prospective study].
    Lüdemann G; Nölle B; Rautmann A; Rosenboom S; Kekow J; Gross WL
    Dtsch Med Wochenschr; 1988 Mar; 113(11):413-7. PubMed ID: 3280286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wegener's granulomatosis--clinical analysis of 18 patients group.
    Dabrowski A; Droszcz W
    Med Sci Monit; 2000; 6(1):151-7. PubMed ID: 11208304
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.